
Opinion|Videos|February 24, 2025
Key Takeaways for Patient-Centered Management of Atopic Dermatitis
Author(s)Raj Chovatiya, MD, PhD, MSCI
The panelist discusses how systemic atopic dermatitis therapies now emphasize targeted biologics and Janus kinase inhibitors, requiring personalized approaches, comprehensive monitoring, and holistic patient management.
Advertisement
Episodes in this series

Video content above is provided by the following:
- Based on our discussion, what key insights or new perspectives could you share regarding treatment considerations for systemic therapies for atopic dermatitis?
- What take-home messages or practice pearls do you have for clinicians treating patients with atopic dermatitis?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Dupilumab Demonstrates Positive Effects on TCS Use, Growth in Pediatric Patients
2
Topical and Systemic Tools Expand Options for Hair Loss, Pigmentary Disorders, and Hand Eczema
3
Pilot Study Tests Oral NAC as Adjunct in Vitiligo Therapy
4
Brian Kim, MD, MTR, FAAD, on the Power of Focus in Research
5





















